| BUY | 17.250 | David King | A potential takeover play. Has been a bit undermanaged and is very cheap. | 2004-04-30 | |
| BUY | 14.680 | Ross Healey | Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline. | 2003-12-19 | |
| PAST TOP PICK | 15.250 | Brian Acker, CA | (A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on. | 2003-09-25 | |
| TOP PICK | 16.120 | Brian Acker, CA | Has great value. US Healthcare looks very inexpensive. | 2003-09-15 | |
| TOP PICK | 14.200 | Peter Arender, CFA | Will be volatile. An OK company at a bargain price. Good risk/reward. | 2003-09-03 | |
| WEAK BUY | 13.970 | Matt Barasch | Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky. | 2003-08-22 | |
| TOP PICK | 13.920 | Brian Acker, CA | (Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap. | 2003-08-12 | |
| TOP PICK | 16.250 | Brian Acker, CA | Systems indicate a top pick. Cheap and has earnings. | 2003-07-14 | |
| DON'T BUY | 15.910 | Brian Acker, CA | Fundamentally should be good, but the stock languishes. | 2002-11-07 | |
| BUY | 19.380 | Robert Floyd | Cheap/ Good growth prospects. Only own a small portion in your portfolio. | 2002-08-16 | |
Experts that have talked about King Pharmaceuticals
Rss Top Picks Feed
